Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares Educational Development Corporation Q1 2026 Earnings Reported Loss of 037 Per Share Stock Declines LINE Q1 2026 Earnings EPS Misses Estimates as Losses Widen Yet Stock Rises NBTB Q1 2026 Earnings EPS Misses Estimates Shares Hold Steady ARCC Q1 2026 Earnings Net Investment Income Misses Estimates Amid Stable Portfolio Performance Exact Sciences Q4 2025 Earnings Significant EPS Miss Highlights Ongoing Investment Challenges